AU2003251650A1 - Screening for agents suitable for treatment of leukocyte associated inflammatory diseases - Google Patents
Screening for agents suitable for treatment of leukocyte associated inflammatory diseasesInfo
- Publication number
- AU2003251650A1 AU2003251650A1 AU2003251650A AU2003251650A AU2003251650A1 AU 2003251650 A1 AU2003251650 A1 AU 2003251650A1 AU 2003251650 A AU2003251650 A AU 2003251650A AU 2003251650 A AU2003251650 A AU 2003251650A AU 2003251650 A1 AU2003251650 A1 AU 2003251650A1
- Authority
- AU
- Australia
- Prior art keywords
- screening
- treatment
- inflammatory diseases
- agents suitable
- associated inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0217503.2 | 2002-07-29 | ||
GBGB0217503.2A GB0217503D0 (en) | 2002-07-29 | 2002-07-29 | Organic compounds |
US41512402P | 2002-09-30 | 2002-09-30 | |
US60/415,124 | 2002-09-30 | ||
PCT/EP2003/008313 WO2004013629A2 (en) | 2002-07-29 | 2003-07-28 | Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003251650A8 AU2003251650A8 (en) | 2004-02-23 |
AU2003251650A1 true AU2003251650A1 (en) | 2004-02-23 |
Family
ID=31497250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003251650A Abandoned AU2003251650A1 (en) | 2002-07-29 | 2003-07-28 | Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1527343A2 (en) |
JP (1) | JP2005534311A (en) |
AU (1) | AU2003251650A1 (en) |
WO (1) | WO2004013629A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080221025A1 (en) * | 2005-01-12 | 2008-09-11 | Sanofi-Aventis Deutschland Gmbh | Use of Trpc Channel for the Treatment of a Cardiovascular Disease |
EP2052724A1 (en) * | 2007-10-26 | 2009-04-29 | sanofi-aventis | Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC6 and TRPC7 ion channel |
KR100953821B1 (en) * | 2007-12-03 | 2010-04-21 | 순천향대학교 산학협력단 | Biomarker for diagnosing asthma and therapeutic agent of asthma controlling expression of vitamin D binding protein |
EP2368876A1 (en) * | 2010-03-01 | 2011-09-28 | Sanofi | Derivatives of aminoindanes, their preparation and their application in therapeutics |
CN103966309B (en) * | 2013-02-04 | 2016-01-27 | 中国科学院上海生命科学研究院 | Peripheral blood cells TRPC6mRNA level is used for early prediction/diagnosis senile dementia |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1099296C (en) * | 1996-01-11 | 2003-01-22 | 韦尔斯利医院基金会 | Compositions including calcium influx retardant for inhibiting cell growth |
AU5229199A (en) * | 1998-07-24 | 2000-02-14 | South Alabama Medical Science Foundation | Use of decreasing levels of functional transient receptor potential gene product |
US20030079243A1 (en) * | 2000-12-11 | 2003-04-24 | Allen Keith D. | Transgenic mice containing TRP6 calcium ion channel gene disruptions |
-
2003
- 2003-07-28 AU AU2003251650A patent/AU2003251650A1/en not_active Abandoned
- 2003-07-28 WO PCT/EP2003/008313 patent/WO2004013629A2/en not_active Application Discontinuation
- 2003-07-28 JP JP2004525342A patent/JP2005534311A/en active Pending
- 2003-07-28 EP EP03766324A patent/EP1527343A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1527343A2 (en) | 2005-05-04 |
AU2003251650A8 (en) | 2004-02-23 |
WO2004013629A2 (en) | 2004-02-12 |
JP2005534311A (en) | 2005-11-17 |
WO2004013629A3 (en) | 2004-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003301347A1 (en) | Methods for monitoring treatment of disease | |
AU2003285091A1 (en) | Interferon antagonists useful for the treatment of interferon related diseases | |
HK1082256A1 (en) | New compounds, compositions and methods for treatment of inflammatory diseases and conditions | |
WO2003072035A8 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004041170A9 (en) | Compositions and methods for the treatment of immune related diseases | |
EP1592384A3 (en) | Cop 1 for treatment of inflammatory bowel diseases | |
WO2004024097A9 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2003228819A1 (en) | Combinations for the treatment of inflammatory skin disorders | |
GB0329874D0 (en) | Compounds useful for the treatment of diseases | |
EP1611120A4 (en) | Novel methods for the treatment of inflammatory diseases | |
AU2003298911A1 (en) | Cyclosporins for the treatment of autoimmune diseases | |
PL371281A1 (en) | Methods and compositions for the treatment of eye diseases | |
AU2003212245A1 (en) | Method of diagnosis of inflammatory diseases using calgranulin c | |
AU2002309180A1 (en) | Composition and kit for the treatment of inflammatory bowel diseases | |
AU2003259833A1 (en) | Methods of treating neurodegenerative diseases | |
WO2004024076A8 (en) | Novel compositions and methods for the treatment of immune related diseases | |
AU2003251650A1 (en) | Screening for agents suitable for treatment of leukocyte associated inflammatory diseases | |
AU2003237150A1 (en) | Compositions and methods for treating inflammatory connective tissue diseases | |
AU2003272962A1 (en) | Remedies for allergic diseases | |
AU2003232844A1 (en) | Morpholin-acetamide derivatives for the treatment of inflammatory diseases | |
AU2003900639A0 (en) | Novel method of treating inflammatory diseases | |
AU2003297912A1 (en) | Methods for screening compounds for use in the treatment of disease | |
AU2003295504A1 (en) | Development of therapeutics for the treatment of endotoxin-mediated diseases | |
AU2003208809A1 (en) | Treatment of neuroblastoma | |
AU2003242246A1 (en) | Remedy for bone mtabolic diseases |